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B
ifidobacteria are Gram-positive members of the human gut microbiota that include species typically representing the dominant colonic bacteria in breast-fed infants (1, 2) . Together with lactobacilli, bifidobacteria are the microorganisms most widely exploited in probiotic formulations because of their various health-promoting properties. In this regard, the ability of Bifidobacterium to interact with the host has been demonstrated to be species and strain specific (3) (4) (5) . Notably, members of the species Bifidobacterium bifidum are capable of interaction with the host, including degradation of mucin (6, 7) , metabolism of human milk oligosaccharides (8) , and modulation of host immune responses (9) (10) (11) . Therefore, the species B. bifidum represents a good source of bacterial strains to be employed for the development of novel effective probiotic (12) or paraprobiotic (13) products.
B. bifidum MIMBb75 is a human intestinal isolate with a marked ability to adhere to intestinal mucosae (6, 8) , transiently colonize murine intestine, and impact the resident microbial communities (14) . Furthermore, the probiotic potential of this strain was evidenced in a clinical trial in which daily consumption of B. bifidum MIMBb75 significantly alleviated the global symptoms of irritable bowel syndrome and improved the quality of life (15) . Though MIMBb75 is efficacious as a probiotic, the molecular mechanisms underlying such interaction are yet largely unknown. For this reason, we undertook whole-genome sequencing of MIMBb75 to identify potential genetic factors useful to elucidate the metabolic and probiotic potentialities of this bacterium.
Type IV secretion systems (T4SSs) are large bacterial protein complexes that transport macromolecules across the cell envelope (16) . Reportedly, T4SSs are involved in naked DNA uptake and release (17) , conjugation (18) , and delivery of effector molecules (DNA and/or protein) into eukaryotic host cells (19) . To support these activities, the proteins constituting T4SSs include (i) peptidoglycan lytic enzymes, (ii) energizing (motor) components, (ii) scaffold/putative core components, and (iv) surface factors/adhesins (20). T4SSs have been studied in detail in certain Gramnegative bacteria, which use these conjugation apparatuses for the translocation of genetic material and effector proteins into other bacteria or eukaryotic host cells (19) . In contrast, T4SSs described so far in Gram-positive bacteria appear to be exclusively dedicated to conjugative DNA transfer, as demonstrated by the presence of members of an additional family of DNA processing enzymes not present in T4SSs participating in protein effector transport (20). Furthermore, Gram-positive conjugative T4SSs do not produce pilus filaments but contain surface proteins that operate as adhesins (21) . It is plausible that T4SSs in Gram-positive cells serve additional and yet unknown purposes.
Although identified in the genome of numerous Gram-positive bacteria, T4SSs have not been characterized in bifidobacteria. In this regard, here we show the identification by comparative genomics of a genetic region putatively coding for a type IV secretion system in B. bifidum MIMBb75. As a first step in the characterization of the putative T4SS of strain MIMBb75, in this study, QIAquick gel extraction kit (Qiagen). Antibiotics for the selection of plasmids were from Sigma-Aldrich (St. Louis, MO). For the preparation of vector pAK-tga, the gene tgaA (without the original signal peptide [SP]) was amplified by PCR from B. bifidum MIMBb75 chromosomal DNA with primers tgaFOR-MA (5=-TTACTCGCGGCCCAGCCGGCCATGG CGACGGAATCCACGGTC-3=) and tgaREV (5=-ATGGTGATCGGCCC CCGAGGCCGTGTGAATGAAGCTGACGCT-3=). The amplicon was digested with SfiI restriction enzyme (SfiI restriction sites in the primers are underlined) and ligated in the same restriction site of vector pAK400 (30) , yielding a transcriptional fusion of the tgaA amplicon with an E. coli pelB signal sequence (SP pelB ) that was present in vector pAK400. The ligation mix was used to transform E. coli JM109 by electroporation according to standard protocols. Recombinants of E. coli JM109 were cultured at 37°C in Super Optimal Broth (SOB) medium supplemented with 25 g ml Ϫ1 chloramphenicol. Once expressed, the signal peptide SP PelB allows the export of the recombinant protein to the periplasm of E. coli cells. For the overexpression of TgaA recombinant proteins, we prepared three plasmids based on expression vector pET26b(ϩ) (Novagen/Merck KGaA, Darmstadt, Germany) and the expression host E. coli BL21(DE3) pLysS (Promega, Madison, WI, USA). In detail, gene tgaA (without the original signal peptide) was amplified by PCR from B. bifidum MIMBb75 chromosomal DNA with primers TgaNdeF (5=-CCTTGGAACATATGAGCG AATCCACGGTCG-3=) and TgaHindR (5=-TCTAGGAAAAGCTTGTGA ATGAAGCTGACG-3=), which include restriction sites NdeI and BamHI, respectively (underlined). The resulting amplicon was digested and ligated in the same restriction sites of vector pET26b(ϩ), yielding a transcriptional fusion with a six-His tag at the 3= terminus of the gene. The resulting vector, named pET-Tga, was subsequently digested with Bsp19I, yielding two DNA fragments. The larger fragment (containing the vector replicon) was separated in and purified from agarose gel and finally selfligated, yielding vector pET-⌬CHAP (where CHAP is cysteine-and histidine-dependent amidohydrolase/peptidase, pfam05257.4). Afterwards, we prepared vector pET-⌬LT (where LT is lytic murein transglycosylase, cd00254.3) by inverse PCR amplification of plasmid pET-Tga with primers dLT-F (5=-ATACCGGAATTCACGGAGACCACCA-3=) and dLT-R (5=-TTCCAATTGAATTCCTGGTCGATCT-3=), followed by digestion of the amplicon with EcoRI (the restriction site is underlined in primer sequences), and self-ligation. The recombinants of E. coli BL21(DE3) pLysS were cultured at 37°C in the presence of 25 g ml Ϫ1 chloramphenicol (selection for pLysS plasmid) and 25 g ml Ϫ1 kanamycin (selection for pET vectors). The absence of mutations or recombinations in the obtained plasmids was confirmed by sequencing analysis. Vectors pAK-Tga, pET-⌬CHAP, and pET-⌬LT were used for the overexpression of the TgaA-derived recombinant proteins.
Analysis of intracellular accumulation of cell wall breakdown products. In order to determine the accumulation of fragments deriving from cell wall lysis in E. coli cells, we used the bioluminescence reporter system based on vector pBlaLux1 and E. coli SNO301 (31) . Briefly, we transformed by electroporation the cell reporter system with vector pAK-Tga. The expression of TgaA recombinant protein from pAK-Tga was obtained by adding isopropyl ␤-D-1-thiogalactopyranoside (IPTG; Sigma-Aldrich) to the cell culture. To assess cell wall lysis, immediately after IPTG addition, the broth cultures were aliquoted in a microtiter plate and incubated at 37°C in a luminometer (Chameleon Multilabel Detection Platform; Hidex OY, Turku, Finland) that was set to automatically measure light emission every 5 min for several hours.
Protein overproduction. Vectors pAK-Tga, pET-⌬CHAP, and pET-⌬LT were used to overexpress in E. coli the recombinant proteins ⌬SP-TgaA-His (containing both domains of TgaA protein; also named SP PelBTgaA here and rTgaA for recombinant TgaA in an accompanying paper [32] ), protein ⌬SP-TgaA-⌬CHAP-His (containing only the LT domain; rLT), and ⌬SP-TgaA-⌬LT-His (containing only the CHAP domain; rCHAP), respectively. To this aim, recombinant E. coli strains were grown over night in 2ϫ YT (yeast extract, tryptone) broth at 37°C and then inoculated in 200 ml of the same medium (1:100 inoculum). After 2 h of incubation under strong agitation at 37°C, 1 mM IPTG was added, and incubation was prolonged for 4 h. Afterwards, cells were recovered by centrifugation, weighed, and treated for protein extraction under denaturing conditions with PerfectPro Ni-nitrilotriacetic acid (NTA) agarose (5 Prime; Eppendorf Italia s.r.l., Milan, Italy) according to the manufacturer's instructions.
Detection of peptidoglycan lytic activity by renaturing SDS-PAGE. Renaturing SDS-PAGE was performed as described by Mora et al. (33) . In brief, autoclaved cells of Micrococcus luteus ATCC 4698 (Sigma-Aldrich) were polymerized using a 12% SDS-PAGE gel at a concentration of 0.2% (wt/vol). Sample preparation was carried out by mixing 5 g of recombinant protein with 30 l of SDS-PAGE denaturing loading buffer. After electrophoresis, gels were soaked in 200 ml of sterilized, distilled water for 30 min and then in 200 ml of 25 mmol liter Ϫ1 Tris-HCl (pH 7) containing 1% (wt/vol) Triton X-100 for 12 to 36 h. Bands of lytic activity were visualized by staining the gel with 1% (wt/vol) methylene blue (Sigma) in 0.1% (wt/vol) KOH and subsequent destaining in sterilized distilled water.
Generation of ⌬SP-TgaA-⌬LT-His-specific antibodies. An antibody against the recombinant protein rCHAP was raised in rabbits by Primm s.r.l. (Milan, Italy). Briefly, after preimmune serum collection, an initial immunization was followed by a second immunization at day 21, a third immunization at day 28, a bleed step and enzyme-linked immunosorbent assay (ELISA) at day 35, and a fourth immunization at day 37. Then, a final serum sampling and affinity purification of antibodies were carried out.
Preparation and analysis of immunofluorescent B. bifidum MIMBb75. B. bifidum MIMBb75 cells were cultivated until early stationary growth phase, harvested by centrifugation, washed once with deionized sterile water, and incubated at room temperature for 10 min with ⌬SP-TgaA-⌬LT-His antiserum (1:100 diluted in deionized water). Subsequently, bacterial cells were centrifuged, resuspended in a solution of Cy5-conjugated goat anti-rabbit secondary antibody (Molecular Probes, Eugene, OR) (1:10 diluted in deionized water), and incubated for 10 min at room temperature in the dark. Afterwards, stained cells were visualized with a fluorescence optical digital microscope (Leica DM1000; Leica Micro-Systems, Wetzlar, Germany) at a magnification of ϫ1,000.
Electron microscopy and immunogold labeling. Bifidobacterial cells were cultivated in broth to stationary phase (15 to 18 h of cultivation) or on agar plates of cMRS medium. Bacterial cells were collected, and the resulting pellet was processed for transmission electron microscopy. Sample preparation was performed according to Arioli et al. (34) . In brief, cells were fixed in 2.5% glutaraldehyde and later postfixed with 1% osmium tetroxide (in 0.1 M cacodylate buffer, pH 7.2) for 2 h at room temperature. After the remaining osmium tetroxide was eliminated, the samples were dehydrated in a graduated cold ethanol series (35 to 100%); each step was performed for about 10 to 15 min at room temperature. The fixed cells were embedded in Epon 812. Blocks were cut with an ultramicrotome and collected on nickel grids. Sections were poststained with 5% uranyl acetate for 5 min at room temperature and treated with lead citrate for 1 min. Sections were observed and photographed with a Philips CM 12 electron microscope and a Zeiss 900 (Carl Zeiss S.p.A., Arese, Milan, Italy). Bacterial cells were also observed after direct staining (intact-cell analysis). For immunogold electron microscopy analysis, samples were treated with anti-⌬SP-TgaA-⌬LT-His rabbit immune serum (or preimmune serum), and the antibodies were then labeled with protein A-conjugated gold particles (10 nm). Finally, the samples were negatively stained with uranyl acetate and lead citrate as indicated above and examined under an electron microscope.
Nucleotide sequence accession number. The DNA sequence of the T4SS region from B. bifidum MIMBb75 has been deposited in the EMBL database under the accession number HG794715.
RESULTS AND DISCUSSION
In silico analysis of the B. bifidum MIMBb75 genome reveals a chromosomal region putatively coding for a type IV secretion system. We generated a draft genome sequence of Bifidobacterium bifidum MIMBb75 consisting of 133 contigs, which in total contained 2.25 Mbp. The guanine and cytosine (GϩC) content was calculated to be 62.76%, which is consistent with that of other B. bifidum genomes (7) .
Comparative genomics revealed that more than 90% of the putative coding sequences identified in MIMBb75's contigs share high sequence homology with all of the B. bifidum genomes available so far (GenBank accession numbers: strain BGN4, NC_017999; PRL2010, NC_014638; S17, NC_014616; IPLA20015, from AMPM01000001 to AMPM01000050; LMG13195, from AMPL01000001 to AMPL01000050). The only exceptions were six chromosomal regions, three of which are related to putative integrated phages or phage remnants (Fig. 1A, regions A, C , and E) and two of which are related to DNA modification enzymes (regions B and D); the other nonconserved genetic locus (region F) consists of a 45-kb region, which includes the putative genes of a type IV secretion system (T4SS).
Even though T4SSs are widespread among all bacterial phyla, their molecular component functions have been studied in depth only within Gram-negative bacteria, such as the vir region of Agrobacterium tumefaciens (35) and the cag type IV secretion apparatus of Helicobacter pylori (36) . The gene nomenclature of the 43-kbp Agrobacterium vir T4SS region has been used to refer also to T4SSs identified in Gram-positive bacteria (37, 38) .
We found 19 putative genes ( Fig. 2A , ORFs 1 to 19) in the predicted T4SS genetic locus of B. bifidum MIMBb75. These putative genes include the minimal components of the secretory system in Gram-positive bacteria (VirB1-, VirB4-, VirB6-, and VirD4-like proteins) and the proteins needed to support the conjugative transfer of DNA (37, 38) . Specifically, we found in MIMBb75 seven genes whose products contain conserved domains associated to vir molecular components of the Agrobacterium tumefaciens T4SS ( Fig. 2A) : ORF4 putatively codes for a VirD2-like relaxase/mobilization protein (conserved domain pfam03432) (Fig. 3, D2) , whereas the polypeptide deduced from ORF8 shows the conserved domains cd01126 and pfam12696, which characterize TraG/TraD/VirD4-like proteins (Fig. 3, D4) ; ORF11 shares homology with a VirB1-type lytic transglycosylase, functioning to degrade peptidoglycan to facilitate insertion of the Gram-positive bacterial type IV secretion machinery into the cell envelope (38-40) ; the ORF12-encoded peptide contains a sequence homologous to the conserved domains pfam12846, TIGR02746, and TIGR00929, which are typical of TrbE/VirB4-like proteins (Fig. 3, B4) . The VirB4-and VirD4-like enzymes of the T4SSs are coupling protein NTPases that play essential roles in supplying the energy for substrate translocation and apparatus assembly (31, 36, 41) . ORF13 putatively codes for VirB6-like proteins (Fig. 3, B6 ), which constitute a component of the transmembrane channel (16) , whereas ORF15 is the potential gene for VirC1 protein, a factor required for efficient DNA transfer (42) . Therefore, the 45-kb genetic locus of B. bifidum MIMBb75 seems to have the main elements necessary for a functional type IV secretion system (Fig. 3 describes the potential mechanism of DNA transfer by the putative T4SS of B. bifidum MIMBb75).
ORF11 encodes TgaA, a putative VirB1-like enzyme. With the aim of characterizing the putative T4SS of B. bifidum MIMBb75, in this study we initially investigated ORF11, which potentially corresponds to a VirB1-like protein. In the T4SS, VirB1 is a protein that harbors a lysozyme-like structural fold. Consistently, we found that the protein encoded by ORF11 contains two conserved domains involved in the metabolism of the bacterial cell wall, lytic murein transglycosylase (LT, cd00254.3) and cysteine-and histidine-dependent amidohydrolase/peptidase (CHAP, pfam05257.4) (Fig. 2B) , according to an organization that resembles the structure of autolytic enzymes (43, 44) . Bacterial lytic transglycosylases degrade murein by nonhydrolytic cleavage of the ␤-1,4-glycosidic bond between N-acetylmuramic acid and N-acetylglucosamine and are part of the autolytic enzymes involved in controlled turnover of the bacterial cell wall (45, 46) . The CHAP domain is found in a wide range of protein architectures, often in association with other domains that cleave peptidoglycan (41, 47) , and presumably shows N-acetylmuramoyl-Lalanine amidase activity (48) . Consequently, the putative gene corresponding to ORF11 was named tgaA for transglycosylase amidase gene A.
Distribution of TgaA protein in bifidobacteria. The overall structure of the TgaA protein (i.e., the LT conserved domain cd00254.3, followed by the CHAP domain pfam05257.4 at the C terminus) was found in eight Bifidobacterium coding sequences available in GenBank, including three putative proteins belonging to the species B. breve and two belonging to B. bifidum. Besides the above-mentioned eight sequences, the LT cassette was found in only one additional putative protein (YP_004209100 from B. longum subsp. infantis 157F) (see Fig. S4 in the supplemental material), whereas a conserved domain of the CHAP superfamily was identified in numerous bifidobacterial putative proteins and particularly in proteins where no other conserved domains are identified (see Fig. S4 ). The CHAP domain is, therefore, widespread among bifidobacteria (18 species), indicating that its enzymatic activity could be involved in cellular functions of fundamental importance for cell wall metabolism (44) . Interestingly, about 14 protein spots in the extracellular proteome of B. animalis subsp. lactis BB-12 were attributed to BIF_00825 and BIF_01398, two proteins containing a CHAP amidase domain (49) . In contrast, in our study we failed to detect any significant positive signal when we tested an MIMBb75 cell-free cMRS broth culture using Western blot analysis with anti-CHAP polyclonal antibodies (data not shown).
TgaA is a peptidoglycan lytic enzyme. We initially verified by reverse transcription-PCR (RT-PCR) that the tgaA gene is expressed by B. bifidum MIMBb75 during the initial exponential growth phase (see Fig. S1 in the supplemental material). Subse- .) The numbers and codes of genes and proteins are according to Fig. 2A . CW, cell wall; CM, cell membrane. The T4SS is comprised of conjugation, effector translocator, and DNA release/uptake subfamilies of proteins. For conjugative transfer, DNA substrates are processed through (i) excision from the chromosome by excisionase/integrase enzymes or transposases (e.g., VirD2), (ii) processing of the transfer intermediate at the origin-of-transfer sequence (oriT) by the relaxosome (e.g., ORF5 and ORF6), (iii) recruitment of the relaxase T-strand intermediate to the type IV coupling proteins (e.g., VirB4/D4), and (iv) translocation through the T4SS channel (e.g., ORF14).
quently, we prepared an engineered E. coli construct expressing a recombinant form of TgaA (SP PelB -TgaA) on IPTG induction in order to biologically confirm the enzymatic activity computationally assigned to the protein TgaA. In SP PelB -TgaA, the original signal peptide of TgaA was replaced by a pelB signal sequence for export at the periplasmic level in E. coli (Fig. 4A) . As an initial confirmation of TgaA lytic activity, we observed a drastic morphological modification of recombinant E. coli cells at the end of the exponential growth phase (Fig. 4B) , which was not detected in the same E. coli strain harboring the empty vector pAK400. In addition, incubation for a few hours of a suspension of wild-type E. coli XL1 with purified SP PelB -TgaA protein resulted in a complete lysis of the bacterial cells (Fig. 4C) .
In a following experiment, we confirmed the lytic activity of TgaA by means of a luminescence reporter system based on vector pBlaLux1 (31) . In pBlaLux1, the luxCDABE operon of Photorhabdus luminescens is under the control of the regulatory element ampR-ampC of Citrobacter freundii (P ampC ), which was demonstrated to be activated by peptidoglycan fragments (see Fig. S2 in the supplemental material). The introduction of the vector ex- pressing SP PelB -TgaA in the microbial biosensor resulted in a double expression system in which the addition of IPTG produced a dose-dependent increase in bioluminescence (Fig. 5) . This experiment showed, therefore, that the intracellular expression of SP PelB -TgaA can cause the accumulation in E. coli cells of peptidoglycan breakdown products, possibly originating from cell wall lysis by TgaA.
Finally, purified SP PelB -TgaA displayed peptidoglycan lytic activity in a renaturing SDS-PAGE assay with cell wall substrates from Micrococcus luteus (see Fig. S3 in the supplemental material) . We ran the same experiment also with the two TgaA protein domains (LT and CHAP), expressed separately by the preparation of recombinant forms of TgaA through overexpression in E. coli. Recombinant proteins lacked the original TgaA signal peptide and were named as follows: protein ⌬SP-TgaA-⌬CHAP-His (containing only the LT domain; rLT) and ⌬SP-TgaA-⌬LT-His (containing only the CHAP domain; rCHAP). Renaturing SDS-PAGE analyses clearly showed TgaA peptidoglycan lytic activity predominantly linked with the transglycosylase domain LT, as confirmed by a distinct band corresponding to the position to which rLT had migrated on SDS-PAGE (Fig. 6 ). In addition, the clarification determined by the rCHAP, although faint, was detectable (Fig. 6) . These results agree with those of Arends et al., who found that both the LT and CHAP domains can degrade peptidoglycan (40) .
In conclusion, our results show unambiguously that the TgaA protein displays peptidoglycan lytic enzymatic activity, which is consistent with the supposed VirB1-like role of this enzyme.
Protein TgaA is expressed on the B. bifidum MIMBb75 cell surface. The enzymatic activity of TgaA protein and its potential role in the putative T4SS suggest its location at cell wall level. Therefore, to confirm the presence and localization of the TgaA protein in B. bifidum cells, we prepared rabbit polyclonal antibodies against a purified recombinant form of TgaA protein. We first studied the presence of TgaA in MIMBb75 cells by fluorescence immunostaining with a goat anti-rabbit phycoerythrin (PE)-Cy5.5 secondary antibody via fluorescence microscopy, which revealed evident fluorescence emission by many cells, particularly by cell aggregates (Fig. 7A) .
In addition, to directly pinpoint TgaA in B. bifidum MIMBb75 cells, we ran experiments using immunogold transmission electron microscopy. The specificity of TgaA recognition by the antibodies was demonstrated by the fact that cell staining was insignificant when we immunolabeled B. bifidum PRL2010, a bifidobacterial strain with no gene in its genome sharing significant sequence similarity with tgaA. In contrast, the electron micrographs showed numerous positive signals in the cytoplasm and, particularly, associated with the cell wall of MIMBb75 (Fig.  7B and C) . Gold particles were also partially distributed in an extracellular matrix (Fig. 7B , frames c to f), which could indicate either a molecule naturally produced by the bacterium (e.g., exopolysaccharides) or cytoplasm extruded from bacterial cells during sectioning. These data confirm that the TgaA protein is abundantly expressed in B. bifidum MIMBb75. In particular, experiments with intact cells established unequivocally that TgaA was present on the outer surface of the bacterial cells (Fig. 7B) , consistent with the role proposed for VirB1-like proteins in T4SS (50) .
Conclusions. The results of this study can be summarized as follows: (i) the genome of Bifidobacterium bifidum MIMBb75 contains a 45-kb region that includes 19 putative genes coding for a potential type IV secretion system; (ii) one gene of this region, named tgaA, putatively encodes the VirB1-like protein of the system, containing two enzymatic domains (lytic transglycosylase LT and amidase CHAP) reportedly associated with peptidoglycan lysis; (iii) we experimentally confirmed that protein TgaA, consistent with its putative VirB1 role, has peptidoglycan lytic activity and is abundantly expressed on the cell surface of B. bifidum MIMBb75.
T4SSs have not been characterized before in bifidobacteria. However, a database search revealed that a genetic region significantly similar to MIMBb75's putative T4SS is also present in the genome of Bifidobacterium bifidum BGN4 (93% nucleotide identity) and Bifidobacterium longum subsp. infantis 157F (91% nucleotide identity). In this study, we undertook the initial characterization of this genetic region, which, according to the literature, can have important implications for bacterial cell-to-cell communication as well as cross talk with host cells (19) . In addition, the localization and abundance of TgaA on the B. bifidum cell surface support the hypothesis that this protein may potentially act as a molecular pattern recognized by host cell receptors at the intestinal level, justifying the interest for further studies aimed at the investigation of the direct interaction of TgaA protein with host cells. Accordingly, in a companion paper (32), we describe the ability of TgaA protein domains to activate dendritic cell maturation.
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